A phase III trial of recombinant human erythropoietin therapy in non-anemic orthopedic patients subjected to aggressive autologous blood phlebotomy: dose, response, toxicity, efficacy. - Goodnough,L.T.; Price,T.H.; Friedman,K.D. (Transfusion, 1994)